INTERNATIONAL PATENT: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER FILES APPLICATION FOR "METHODS AND COMPOSITIONS FOR TREATING CANCER USING N-MYRISTOYLTRANSFERASE INHIBITORS"

GENEVA, March 11 -- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER (1124 West Carson StreetTorrance, California 90502) filed a patent application (PCT/US2025/043026) for "METHODS AND COMPOSITIONS FOR TREATING CANCER USING N-MYRISTOYLTRANSFERASE INHIBITORS" on Aug 21, 2025. With publication no. WO/2026/050089, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DIAZ FERNANDEZ, Maria Begoña (1124 West Carson StreetTorrance, California 90502)

Abstract: Methods of treating a subject for cancer a...